Page last updated: 2024-10-26

dipyridamole and Leukemia, Lymphoid

dipyridamole has been researched along with Leukemia, Lymphoid in 4 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research Excerpts

ExcerptRelevanceReference
"Dipyridamole use was related to a lower risk of lymphoid neoplasms, indicating a clinical potential of dipyridamole to be an adjunct anti-tumour agent against lymphoid neoplasms."1.72Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study. ( Huang, W; Ji, J; Sundquist, J; Sundquist, K, 2022)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Huang, W1
Sundquist, K1
Sundquist, J1
Ji, J1
Edwards, NL1
Recker, D1
Manfredi, J1
Rembecki, R1
Fox, IH1
Ullman, B1
Coons, T1
Rockwell, S1
McCartan, K1
Hirose, M1
Takeda, E1
Ninomiya, T1
Kuroda, Y1
Miyao, M1

Other Studies

4 other studies available for dipyridamole and Leukemia, Lymphoid

ArticleYear
Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study.
    British journal of haematology, 2022, Volume: 196, Issue:3

    Topics: Aged; Aged, 80 and over; Aspirin; Chemoprevention; Comorbidity; Dipyridamole; Disease Susceptibility

2022
Regulation of purine metabolism by plasma membrane and cytoplasmic 5'-nucleotidases.
    The American journal of physiology, 1982, Volume: 243, Issue:5

    Topics: 5'-Nucleotidase; Adenosine Diphosphate; B-Lymphocytes; Cell Line; Cell Membrane; Cytoplasm; Dipyrida

1982
Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
    The Journal of biological chemistry, 1988, Sep-05, Volume: 263, Issue:25

    Topics: Acquired Immunodeficiency Syndrome; Biological Transport; Cell Division; Cell Survival; Deoxycytidin

1988
Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.
    British journal of cancer, 1987, Volume: 56, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Dipyridamole; Dose-Response Relati

1987
chemdatabank.com